Department of Genetics, Centre for Excellence in Genomic Sciences, School of Biological Sciences, Madurai Kamaraj University, Madurai, Tamil Nadu, India.
PLoS One. 2013 Jul 2;8(7):e69316. doi: 10.1371/journal.pone.0069316. Print 2013.
Development of resistant variants to existing antifungal drugs continues to be the serious problem in Candida albicans-induced fungal pathogenesis, which has a considerable impact on animal and human health. Identification and characterization of newer drugs against C. albicans is, therefore, essential. MMGP1 is a direct cell-penetrating peptide recently identified from marine metagenome, which was found to possess potent antifungal activity against C. albicans.
METHODOLOGY/PRINCIPAL FINDINGS: In this study, we investigated the mechanism of antifungal action of MMGP1 against C. albicans. Agarose gel shift assay found the peptide to be having a remarkable DNA-binding ability. The modification of the absorption spectra and fluorescence quenching of the tryptophyl residue correspond to the stacking between indole ring and nucleotide bases. The formation of peptide-DNA complexes was confirmed by fluorescence quenching of SYTO 9 probe. The interaction of peptide with plasmid DNA afforded protection of DNA from enzymatic degradation by DNase I. In vitro transcription of mouse β-actin gene in the presence of peptide led to a decrease in the level of mRNA synthesis. The C. albicans treated with MMGP1 showed strong inhibition of biosynthetic incorporation of uridine analog 5-ethynyluridine (EU) into nascent RNA, suggesting the peptide's role in the inhibition of macromolecular synthesis. Furthermore, the peptide also induces endogenous accumulation of reactive oxygen species (ROS) in C. albicans. MMGP1 supplemented with glutathione showed an increased viability of C. albicans cells. The hyper-produced ROS by MMGP1 leads to increased levels of protein carbonyls and thiobarbituric acid reactive substances and it also causes dissipation of mitochondrial membrane potential and DNA fragmentation in C. albicans cells.
And Significance: Therefore, the antifungal activity of MMGP1 could be attributed to its binding with DNA, causing inhibition of transcription followed by endogenous production of ROS, which triggers cascade of events that leads to cell death.
现有抗真菌药物的耐药变体的发展仍然是白色念珠菌真菌感染发病机制中的严重问题,这对动物和人类健康有相当大的影响。因此,识别和表征针对白色念珠菌的新型药物是必要的。MMGP1 是一种最近从海洋宏基因组中鉴定出的直接穿透细胞膜的肽,被发现对白色念珠菌具有很强的抗真菌活性。
方法/主要发现:在这项研究中,我们研究了 MMGP1 对白色念珠菌的抗真菌作用机制。琼脂糖凝胶迁移实验发现该肽具有很强的 DNA 结合能力。色氨酸残基吸收光谱和荧光猝灭的修饰对应于吲哚环和核苷酸碱基之间的堆积。SYTO 9 探针的荧光猝灭证实了肽-DNA 复合物的形成。肽与质粒 DNA 的相互作用使 DNA 免受 DNase I 的酶降解。在存在肽的情况下,体外转录小鼠β-肌动蛋白基因导致 mRNA 合成水平降低。用 MMGP1 处理的白色念珠菌显示出强烈抑制尿嘧啶类似物 5-乙炔基尿嘧啶(EU)掺入新生 RNA 的生物合成,表明该肽在抑制大分子合成中的作用。此外,该肽还诱导白色念珠菌内源性活性氧(ROS)的积累。用谷胱甘肽补充 MMGP1 后,白色念珠菌细胞的活力增加。MMGP1 产生的超量 ROS 导致蛋白质羰基和硫代巴比妥酸反应物质水平升高,并导致白色念珠菌细胞中线粒体膜电位和 DNA 片段化的耗散。
因此,MMGP1 的抗真菌活性可能归因于其与 DNA 的结合,导致转录抑制,随后内源产生 ROS,引发一系列导致细胞死亡的事件。